Article: Co-Diagnostics Inc. [CODX] stock Reiterated by H.C. Wainwright analyst, price target now $20

Article - Media

Co-Diagnostics Inc. [CODX] stock Reiterated by H.C. Wainwright analyst, price target now $20

Brandon Evans

DBT News, 30 April 2020

Co-Diagnostics Inc. [NASDAQ: CODX] traded at a low on 04/29/20, posting a -8.57 loss after which it closed the day’ session at $12.37. The results of the trading session contributed to over 5099148 shares changing hands. Over the past one week, the price volatility of Co-Diagnostics Inc. stands at 10.98% while the volatility over the past one month is 12.61%.

The market cap for CODX stock reached $332.63 million, with 26.89 million shares outstanding and 20.80 million shares in the current float. Compared to the average trading volume of 12.82M shares, CODX reached a trading volume of 5099148 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Read full article.

 

Comment: This company is at risk of collusion between a placement agent and naked short sellers.

RELATED:

Paper: ETF Short Interest and Failures-to-Deliver: Naked Short-Selling or Operational Shorting?

Paper

ETF Short Interest and Failures-to-Deliver: Naked Short-Selling or Operational Shorting?

Richard B. Evans, Rabih Moussawi, Michael S. Pagano, John Sedunov

Darden Business School, 3 May 2017

We identify an alternative source of ETF shorting related to the market maker liquidity provision and creation/redemption activities. This “operational shorting” arises due to a regulatory exemption, allowing ETF market makers to satisfy excess demand in secondary markets by selling ETF shares that have not yet been created.

PDF (79 pages): ETF Short Interest and Failures-to-Deliver: Naked Short-Selling or Operational Shorting?